AngioDynamics
ANGO
149 hedge funds and large institutions have $721M invested in AngioDynamics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 51 reducing their positions, and 6 closing their positions.
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
11% more funds holding
Funds holding: 134 → 149 (+15)
5% more capital invested
Capital invested by funds: $686M → $721M (+$35.7M)
0.92% less ownership
Funds ownership: 96.27% → 95.35% (-0.92%)
6% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.79M |
| 3 |
ACM
Altium Capital Management
New York
|
+$3.41M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$2.6M |
| 5 |
BlackRock
New York
|
+$2.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$13M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.59M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.93M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.03M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
HSBC Holdings
London,
United Kingdom
| – | -$197K | -10,255 | Closed |
|
152
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$58K | -3,019 | Closed |
|
|
VVP
153
Venture Visionary Partners
Sylvania,
Ohio
| – | -$7.74K | -400 | Closed |
|
|
CWP
154
Concord Wealth Partners
Abingdon,
Virginia
| – | -$8K | -388 | Closed |
|
155
Rockefeller Capital Management
New York
| – | -$834 | -38 | -69% |
|
ANGO Hedge Fund Activity: Q3 2022 in Review
149 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2022, worth a combined $721M — up 5.2% from $686M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ANGO positions and 6 closed out — a net gain of 16 holders — while 48 added to existing stakes and 51 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $19.3M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $13M sold.
- 149 institutional investors held AngioDynamics (ANGO) as of Q3 2022, up from 134 in Q2 2022.
- Funds reported $721M of AngioDynamics stock for Q3 2022, up 5.2% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q3 2022 and 6 closed out, a net change of +16 holders.
- The largest AngioDynamics buyer in Q3 2022 was Fidelity Investments, an estimated $19.3M added.
- The largest AngioDynamics seller in Q3 2022 was Soleus Capital Management, an estimated $13M sold.
Based on aggregated 13F filings for Q3 2022.